Studies show that patients losing 5-10% body weight may require 10-25% reductions in levothyroxine dosing to maintain optimal TSH levels
References Allocati N, Masulli M, Di llio C, Federici L (2018) Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
Already, Wegovy has been approved to reduce the risk of heart problems
States Consultations Starting at $79 Schedule a Consultation This article is provided for educational purposes only and does not constitute medical advice, diagnosis, or a personal treatment recommendation
Lancet Diabetes Endocrinol (2018) 6:27586
The GCL enzyme is a heterodimer formed by two subunits: the heavy subunit or glutamate cysteine ligase catalytic subunit (GCLC, 73 kDa) and the light subunit or glutamate cysteine ligase modulating subunit (GCLM, 30 kDa)